About
Arturo Loaiza-Bonilla, MD, MSEd, FACP, is Co-Founder and Chief Medical AI Officer at Massive Bio and Systemwide Chief of Hematology and Medical Oncology at St. Luke's University Health Network, where he oversees oncology across 16 hospital campuses in Pennsylvania and New Jersey. He has led Phase I–III clinical trial portfolios at institutions including Penn Medicine, Sylvester Comprehensive Cancer Center, Cancer Treatment Centers of America, and Capital Health, and is named as inventor on four U.S. patent applications related to AI-driven precision oncology. His research includes more than 80 peer-reviewed publications, and he holds roles such as ASCO AI Community of Practice Champion, NeurIPS 2025 Program Chair, Senior Research Collaborator at Meta Superintellig
Founder at Massive Bio
Intro paths
→
In turn, Arturo can intro founders to Massive Bio's investors below.
Massive Bio's investors · 5
Co-founders at Massive Bio
SK
Selin KurnazExecutive Officer
Experience
- St. Luke's University Health NetworkNetwork Chief of Hematology and Oncologycurrent2024 — presentPennsylvania, United States
- Temple University - Lewis Katz School of MedicineAssociate Professor of Medicinecurrent2024 — present
- Massive BioCo-Founder & Chief Medical AI Officer (CMAIO)current2015 — presentNew York
- OpenAIAI in Health Member and Contributorcurrent2024 — present
- National Cancer Institute (NCI)Invited Expert - National Framework for AI Benchmarks in Cancer Carecurrent2026 — present
- American Society of Clinical Oncology (ASCO)Advisory Committee - Artificial Intelligence CoP Champion, Government Relations & AMA RUCcurrent2022 — presentUnited States
- SkyMedAIMedical AI Advisor Precision Medicine & Oncologycurrent2025 — presentUnited States
- CancerX MoonshotAccelerator Mentor - Founding Membercurrent2024 — present
- HEARTioInvestor and Product Development Boardcurrent2025 — presentUnited States
- AI in Precision OncologyEditorial Boardcurrent2024 — present
- Drexel University College of MedicineTeaching Faculty, Department of Medicinecurrent2020 — present
- BrightInsight, a Flex CompanyClinical Board Membercurrent2018 — present
- Pennsylvania Society of Oncology and HematologyPresident (2020-2022)current2018 — presentHarrisburg, Pennsylvania Area
- Pennsylvania Society of Oncology and HematologyBoard Membercurrent2014 — presentHarrisburg, Pennsylvania
- NeurIPSProgram Chair2025
- Capital Health (US)Systemwide Chair of Medical Research2023 — 2024
- Capital Health (US)Medical Director of Oncology Research2022 — 2024Pennsylvania, United States
- VidenceSenior Medical Director2020 — 2022Boca Raton, Florida, United States
- Cancer Treatment Centers of AmericaVice Chairman Of The Department Of Medical Oncology2018 — 2022
- Cancer Treatment Centers of AmericaEnterprise Medical Director of Research2017 — 2022Philadelphia, Pennsylvania
- PhilipsPhilips HealthWorks Fellow2018Greater Boston Area
- Penn Medicine, University of Pennsylvania Health SystemAssistant Professor, Gastrointestinal Oncology - Abramson Cancer Center2012 — 2017
- ECOG-ACRIN Cancer Research GroupEsophagogastric Cancer Task Force Investigator2015 — 2016
Skills & more
Product Management1New Product Rollout1Medical Affairs1Business DevelopmentProgram OversightProgram CoordinationAcademic Program ManagementProduct DevelopmentClass III Medical DevicesRegulatory ComplianceMedical Device R&DBig Data1
+12 more
Computational ModelingBusiness StrategyQuantum ComputingPrecision MedicineBiotechnologyEditorial ProductionEditorial Product DevelopmentDeal ClosureFoundational ModelsSoftware as a Service (SaaS)EMRTeam LeadershipLanguages English · French · Japanese · Spanish
- Data or Specimens Only Research — CITI Program
- AI in Healthcare Specialization — Stanford University
- Evaluations of AI Applications in Healthcare — Stanford University Department of Computer Science
- Microsoft for Startups Founders Hub — Microsoft
- Fundamentals of AI and Machine Learning in Healthcare — Stanford University School of Medicine
- Artificial Intelligence in Health Care — MIT Sloan School of Management
- Physician And Surgeon (Allopathic - M.D.) — Pennsylvania Department of State
- Medical Oncology — American Board of Internal Medicine
- Hematology — American Board of Internal Medicine
- Internal Medicine — American Board of Internal Medicine
From Arturo's professional profile.
Frequently asked questions
- Who is Arturo Loaiza-Bonilla?
- Arturo Loaiza-Bonilla, MD, MSEd, FACP, is Co-Founder and Chief Medical AI Officer at Massive Bio and Systemwide Chief of Hematology and Medical Oncology at St. Luke's University Health Network, where he oversees oncology across 16 hospital campuses in Pennsylvania and New Jersey. He has led Phase I–III clinical trial portfolios at institutions including Penn Medicine, Sylvester Comprehensive Cancer Center, Cancer Treatment Centers of America, and Capital Health, and is named as inventor on four U.S. patent applications related to AI-driven precision oncology. His research includes more than 80 peer-reviewed publications, and he holds roles such as ASCO AI Community of Practice Champion, NeurIPS 2025 Program Chair, Senior Research Collaborator at Meta Superintellig
- Where does Arturo Loaiza-Bonilla work?
- Arturo Loaiza-Bonilla is Founder of Massive Bio.
- What companies did Arturo Loaiza-Bonilla found?
- Arturo Loaiza-Bonilla founded Massive Bio.
- Where did Arturo Loaiza-Bonilla go to school?
- Arturo Loaiza-Bonilla studied at University of Pennsylvania (Master of Medical Education, MSEd); University of Miami Miller School of Medicine (Post-Doctorate Fellow, Hematology and Oncology); The Johns Hopkins University School of Medicine (Residency, Internal Medicine).
Same school
Also attended University of Pennsylvania1,074
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,068 more
Also attended University of Miami Miller School of Medicine6
Beth SeidenbergFounding Managing Director at Westlake Village BioPartnersRichard FryeDirector Of Autism Research, Arkansas Children's Hospital at AIFRasciel SocarrasAdvisory Board Member at HLM Venture PartnersNadine HousriFounder/Chief Medical Officer at MednetJonathan SpornFounder at Gilgamesh PharmaceuticalsKaushal Kulkarni, M.D.Founder at Predoc
Also attended The Johns Hopkins University School of Medicine43
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersStephen P. ZacharyManaging Partner at Sands Capital VenturesNamita KumariAssociate, Technical Research at Sands Capital VenturesS.K. LeeExecutive Coach at Roble Ventures
.png)
+ 37 more
Also attended Universidad Nacional de Colombia6
Shared employers
Also worked at OpenAI138
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockPat GradyPartner at Sequoia CapitalGreg BrockmanCo-founder & President of OpenAIDario AmodeiCo-founder & CEO of AnthropicDaniela AmodeiCo-founder & President of AnthropicFraser KeltonInvestor at Spark Capital
+ 132 more
Also worked at Philips139
Paul van OoikInvestment associate at NoaberLidwi van OsProgram & Office Support Officer at NoaberDaniel GrafGeneral Partner at redalpineRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalNeelam DhawanTech Industry Trailblazer at SenseAI VenturesJoel CraterGeneral Partner at Cultivation Capital
+ 133 more